Details of the Drug

General Information of Drug (ID: DMBE5OK)

• Drug Name: AZD7798

Indication

Disease Entry	ICD 11	Status	REF
Crohn disease	DD70	Phase 1	[1]

• Drug Type: Antibody
• Cross-matching ID: TTD ID: DE3LH7

References

• [1] ClinicalTrials.gov (NCT05452304) A Phase 1 Randomised, Double-Blind, Placebo-Controlled 3 Part Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7798 Following Single Ascending Dose Administration and Repeat Dose Administration in Healthy Subjects (Including Japanese and Chinese Subjects), and Patients With Crohn's Disease. U.S.National Institutes of Health.